Main > ONCOLOGY (**) > Bladder Cancer>mUC *** > Treatment > USA. M. PembrolizuMAb

---

USA. M. PembrolizuMAb's subsections
(*) EU Approval Date: 2017. 09.05
(*) JP Approval Date: 2018. 01.02
(*) USA Approval Date: 2017. 05.18
>Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2019. 12.31.
TradeMark
TradeMark Web-Site

USA. M. PembrolizuMAb's products
This section has no products